In January 2026, the Centers for Medicare & Medicaid Services (CMS) launched the Wasteful and Inappropriate Service Reduction (WISeR) model, a bold—and highly controversial—attempt to overhaul the fiscal trajectory of traditional Medicare. By introducing prior authorization protocols and leveraging cutting-edge artificial intelligence, the program sought to curtail the ballooning costs associated with duplicative and low-value medical services.
However, less than five months into its rollout, the initiative finds itself at a precarious crossroads. A coalition of Congressional Democrats has initiated a formal legislative challenge to dismantle the program, citing systemic risks to patient safety, health equity, and the integrity of the traditional Medicare benefit. As the clock ticks on a 60-day congressional review window, the healthcare industry, policymakers, and millions of beneficiaries remain caught in a tug-of-war that pits administrative efficiency against the fundamental promise of accessible, doctor-directed care.
The Genesis of WISeR: A New Paradigm for Traditional Medicare
The WISeR model was designed as a targeted intervention to address the rising tide of medical spending within the traditional Medicare program. Unlike Medicare Advantage, which has long utilized prior authorization as a standard cost-containment tool, traditional Medicare has historically operated with fewer administrative barriers to care.
Operational Scope and Partnerships
The pilot program is currently being tested in a geographically diverse set of states: Arizona, New Jersey, Ohio, Oklahoma, Texas, and Washington. To manage the massive data requirements of the program, CMS partnered with a cohort of technology vendors, including Cohere Health, Genzeon Corporation, Humata Health, Innovaccer, Virtix Health, and Zyter.
The core of the WISeR model is the integration of AI-driven decision-making tools. These systems analyze clinical data to determine the medical necessity of procedures before they are performed. While proponents argue that this creates a more sustainable healthcare system, critics contend that it fundamentally shifts the power dynamic between the physician and the insurer, turning the latter into an algorithmic gatekeeper.
Chronology of the Legislative Pushback
The path to the current confrontation was paved by a series of legal and procedural developments that have placed the Trump administration’s signature policy under the microscope.
- January 2026: CMS officially launches the WISeR model, deploying AI-driven prior authorization across six pilot states.
- Early 2026: Anecdotal reports begin to surface regarding technical friction, delayed approvals, and high denial rates compared to established Medicare Advantage benchmarks.
- May 12, 2026: The Government Accountability Office (GAO) issues a pivotal determination. The agency concludes that WISeR imposes significant new requirements on providers, effectively categorizing it as a "rule" subject to the Congressional Review Act (CRA).
- May 20, 2026: A group of high-profile Congressional Democrats—including Sen. Ron Wyden (D-Oregon), Rep. Suzan DelBene (D-Washington), and Rep. Greg Landsman (D-Ohio)—introduce a joint resolution of disapproval to repeal the model.
- Late May 2026–Present: The 60-day legislative window opens, creating a high-pressure environment for Congress to determine the fate of the model before the clock expires.
The Controversy: AI, Denials, and the Patient Experience
The opposition to WISeR is not merely political; it is rooted in profound concerns regarding the intersection of automation and patient welfare. Neil Patil, senior fellow and policy director at the Medicare Policy Initiative at Georgetown’s Center on Health Insurance Reform, has been a leading voice in articulating these risks.
The Problem with Algorithmic Gatekeeping
"There have been a lot of concerns around the use of artificial intelligence and algorithms to apply prior authorization because of some reports that they may be inappropriately denying care, just based on some of the underlying algorithms that are used," Patil explained in a recent interview.
The concern is twofold. First, there is the "black box" nature of proprietary AI, which can obscure the rationale behind a denial, making it difficult for providers to contest decisions. Second, there is the potential for these algorithms to exacerbate health disparities, particularly if the training data used to build them reflects historical biases in healthcare access.
The Financial Burden on Beneficiaries
Beyond the clinical implications, prior authorization introduces administrative complexity that often lands on the shoulders of the patient. When a claim is denied, the patient is forced to navigate complex appeals processes, often while suffering from the very condition that prompted the request for care. This can lead to increased out-of-pocket costs and significant delays in treatment—a scenario that contradicts the core mission of traditional Medicare.
Incentivizing Denial: The Outsourcing Dilemma
A particularly contentious aspect of the WISeR model is its financial structure. Under the pilot, outside contractors receive 10% to 20% of the savings generated by reduced spending.
Michael Abrams, managing partner of the consulting firm Numerof & Associates, argues that this creates a perverse incentive structure. "When you incentivize denial of service, you get more denials of service," Abrams noted. He points to the experience in Medicare Advantage, where roughly 75% to 82% of denials are overturned on appeal, suggesting that the initial denials were often baseless or bureaucratic errors rather than genuine instances of "wasteful" care.
Abrams further warns against the industry trend of aggressive cost-cutting. "The country has yet to finish dealing with the murder of a major insurance company executive in which denial of service reportedly played a role," he stated, referencing the 2024 killing of UnitedHealthcare CEO Brian Thompson. "Building the same flaws that make Medicare Advantage problematic into traditional Medicare would seem a monumental mistake."
Official Responses and Stakeholder Positions
AARP’s Stance
As the largest advocacy group for older Americans, the AARP has voiced deep reservations about the program. A spokesperson for the organization emphasized that while the group supports efforts to eliminate fraud, the burden of proof should not fall on the patient. "The health care of older Americans must always come first, and nobody should be denied legitimate treatments they need," the spokesperson stated. The AARP continues to advocate for the sanctity of the doctor-patient relationship, arguing that decisions should be made in the exam room, not by an algorithm.
The Political Outlook: Will the Resolution Succeed?
The success of the repeal effort remains uncertain. While the Congressional Review Act provides a streamlined mechanism for overturning federal rules, the political reality is complex.
According to Neil Patil, the primary hurdle is the administration that birthed the policy. "Given that this is the Trump administration’s own model that they introduced, I would imagine it’s pretty unlikely that the president would go ahead and sign on and terminate this model," he noted.
Even if the resolution passes both the House and the Senate, it would face a near-certain veto from President Trump. The only scenario in which the model is repealed would be if the resolution garners such overwhelming, bipartisan support that a veto becomes politically untenable.
Implications: A Watershed Moment for Healthcare Policy
The WISeR model represents a fundamental debate about the role of the federal government in managing healthcare. If it remains in place, it signals a shift toward a more managed-care approach within traditional Medicare, emphasizing cost-containment through technology. If it is repealed, it underscores the strength of the resistance against administrative interference in clinical care.
Looking Ahead
The coming weeks will be critical. The 60-day window following the GAO determination serves as a litmus test for how Congress handles the rapid adoption of AI in federal programs.
If the WISeR model continues, the industry will need to see significantly more transparency regarding the algorithms used to make coverage determinations. Without a clear path to accountability, the program risks alienating the very providers it relies on to deliver care. Conversely, if the program is dismantled, policymakers will need to find alternative, less intrusive ways to address the valid concerns regarding wasteful spending in the Medicare program.
As it stands, the WISeR model is "out of step with the national experience in healthcare insurance," according to Abrams. Whether that disconnect results in a total program collapse or a drastic restructuring remains to be seen. What is clear is that the reliance on AI to dictate the terms of care is a high-stakes experiment—and the patients of traditional Medicare are the ones who stand to lose the most if the system fails.
